A clinical trial of intravenous and intracavitary bleomycin.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001344:Autopsy; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D008168:Lung / Q000473:pathology; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D012888:Skull Neoplasms / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin